Persistence of epstein-barr virus in vivo
Phase of Trial: Phase III
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Valaciclovir (Primary)
- Indications Epstein-Barr virus infections
- Focus Therapeutic Use
- 03 Feb 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 21 Sep 2008 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 13 Jul 2007 New trial record.